![]() |
市場調查報告書
商品編碼
1370618
生物樣本庫市場- 按產品[設備(儲存、樣本分析、處理、運輸)、消耗品、服務、軟體]、樣本(血液、組織、細胞系)、應用(再生醫學)、儲存類型、最終用戶、全球預測(2023-2032)Biobanking Market - By Product [Equipment (Storage, Sample Analysis, Processing, Transport), Consumable, Service, Software], Sample (Blood, Tissue, Cell Line), Application (Regenerative Medicine), Storage Type, End-user, Global Forecast (2023-2032) |
從2023 年到2032 年,生物樣本庫市場將以7.2% 的年複合成長率成長。對個人化醫療、基因組學和藥物發現的日益關注,需要廣泛的生物樣本庫來儲存和分析,這將推動市場向前發展。
對生物標記識別和疾病研究的需求不斷成長,以及生物銀行、研究機構和製藥公司之間的合作不斷增加,推動了業務擴張。
認知到保存生物樣本對於未來研究和醫學進步的重要性將吸引投資並推動生物樣本庫產業的成長。 2021 年 10 月,賽默飛世爾科技推出了一系列合規、永續的血庫冰箱,專門用於儲存血液和相關樣本,以造福醫療保健專業人員和臨床研究人員。
整個生物樣本庫市場根據產品和服務、樣本類型、應用、儲存類型、最終用戶和地區進行分類。
到 2032 年,消耗品產品和服務領域的年複合成長率將達到 6.8%。這是由於對樣本採集和儲存解決方案的需求不斷成長。研究、診斷和藥物開發中對樣品保存的需求不斷成長,將促進該領域的成長。
根據樣本類型,到 2032 年,人體組織樣本領域的年複合成長率將達到 7.3%。對生物標記研究和個人化醫療的不斷成長的需求將推動該領域的成長。為了推進醫學研究和開發有針對性的治療方法,對保存完好的人體組織樣本的需求不斷成長,也將促進該領域的成長。
到 2032 年,由於對有據可查的樣本的需求不斷成長,以推進藥物發現和精準醫療,臨床研究應用領域的年複合成長率將達到 7.5%。生物樣本庫和研究機構之間的合作以及臨床試驗的擴大將進一步促進該領域的成長。
從地區來看,亞太地區生物樣本庫市場在分析期間將以 7.5% 的年複合成長率成長。不斷增加的研究活動,特別是基因組學和個人化醫學的研究活動,將推動該地區對生物樣本庫的需求。此外,與國際研究機構加強合作以及日益認知到生物樣本庫對醫學研究的重要性也將影響區域產業動態。
The biobanking market will grow at a 7.2% CAGR from 2023 to 2032. Increasing focus on personalized medicine, genomics, and drug discovery, necessitating extensive biorepositories for large-scale sample storage and analysis will drive the market ahead.
The growing demand for biomarker identification and disease research, alongside collaborations between biobanks, research institutions, and pharmaceutical companies have increased, fueling business expansion.
The recognition of the importance of preserving biological specimens for future studies and medical advancements will attract investments and drive growth in the biobanking industry. In October 2021, Thermo Fisher Scientific introduced a range of compliant, sustainable blood bank refrigerators tailored for the storage of blood and related samples, for the benefit of healthcare professionals and clinical researchers.
The overall biobanking market is segregated based on product & service, sample type, application, storage type, end-user, and region.
The consumables product & service segment will exhibit a 6.8% CAGR through 2032. This is attributed to the increasing demand for sample collection and storage solutions. The rising need for sample preservation in research, diagnostics, and drug development will augment growth in the segment.
Based on sample type, the human tissues sample segment will depict a 7.3% CAGR through 2032. The expanding need for biomarker research and personalized medicine will drive growth in the segment. The accelerating demand for well-preserved human tissue samples to advance medical research and develop targeted treatments will also foster growth across this segment.
The clinical research application segment will reflect 7.5% CAGR through 2032, driven by the increasing demand for well-documented samples to advance drug discovery and precision medicine. Collaborations between biobanks and research institutions and the expansion of clinical trials will further augment growth in the segment.
Regionally, the Asia Pacific biobanking market will grow at 7.5% CAGR during the analysis period. Rising research activities, especially in genomics and personalized medicine, will drive the demand for biorepositories in the region. In addition, increasing collaborations with international research institutions and the growing awareness of the importance of biobanking for medical research will also influence regional industry dynamics.